Cyclophosphamide and water retention: Mechanism revisited

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 6, 2000, Pages 673-675

  Campbell, Douglas M ^a   Atkinson, Adele ^a   Gillis, David ^b   Sochett, Etienne B ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Antidiuresis; Bone marrow transplantation; Cyclophosphamide; Diabetes insipidus; Posterior pituitary

Indexed keywords

ALLOPURINOL; CARBOPLATIN; CISPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DESMOPRESSIN; DEXAMETHASONE; ETOPOSIDE; FLUCONAZOLE; HYDROCORTISONE; IFOSFAMIDE; LEVOTHYROXINE; MESNA; ONDANSETRON; PARACETAMOL; VASOPRESSIN;

ANTIDIURESIS; ARTICLE; CASE REPORT; DIABETES INSIPIDUS; DRUG EFFECT; DRUG SAFETY; DYSGERMINOMA; FEMALE; HUMAN; RELATIVE DENSITY; SCHOOL CHILD; URINE VOLUME; VASOPRESSIN RELEASE; WATER INTOXICATION; WATER RETENTION;

EID: 0033948895     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.6.673     Document Type: Article

References (9)

1. Santos GW. Bone marrow graft in human disease - its problems and potential. In: Hanna MF, ed. Current Problems in Immunobiology. New York: Plenum Publishing Company, 1972; 143-184.
2. Buckner CD, Rudolph RH, Fefer A, Clift RA, Epstein RB, Funk DD, Neiman PE, Slichter SJ, Storb R, Thomas ED. High-dose cyclophosphamide therapy for malignant disease. Cancer 1972; 29: 357-365.
3. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E. A fatal case of inappropriate AVP secretion induced by cyclophosphamide therapy. Cancer 1979; 44: 896-898.
4. DeFronzo RA, Colvin OM, Braine H, Robertson GL, Davis PJ. Cyclophosphamide and the kidney. Cancer 1974; 33: 483-491.
5. Steele TH, Serpick AA, Block JB. Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther 1979; 185: 245-253.
6. McCarron MO, Wright GD, Roberts SD. Water intoxication after low dose cyclophosphamide. Br Med J 1995; 311: 292.
7. Haas A, Chin T, Stiehm ER. Cyclophosphamide-induced water intoxication: Treatment with fluid restriction and 2-mercaptoethane sulfonate. Am J Dis Child 1986; 140: 1094-1095.
8. Chabner BA, Allegra CJ, Curt GA, Calabresi P. Anti-neoplastic agents. In: Hardman JG, Limbird LE, Molinooff PB, et al., editors. Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 9th Ed. New York: McGraw-Hill, 1996; 1233-1288.
9. Fujiwara TM, Morgan K. Molecular biology of diabetes insipidus. Ann Rev Med 1995; 46: 331-343.